Reirradiation for progressive brain metastases
Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the pr...
Gespeichert in:
Veröffentlicht in: | Journal of cancer research and therapeutics 2009-07, Vol.5 (3), p.161 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | 161 |
container_title | Journal of cancer research and therapeutics |
container_volume | 5 |
creator | Bahl, Amit Kumar, Milind Sharma, D N Jothy Basu, K S Jaura, M S Rath, G K Julka, P K |
description | Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the primary modality for the treatment of multiple brain metastases, and improves both the quality of life and survival of patient. Unfortunately, more than half of these treated patients eventually progress leading to a therapeutic dilemma. Another course of radiotherapy is a viable but underutilized option. Reirradiation resolves distressing symptoms and has shown to improve survival with minimal late neurotoxicity. Reirradiation has conventionally been done with whole brain radiotherapy, but now studies with stereotactic radiosurgery have also shown promising results. In this review, we focus on reirradiation as a treatment modality in such patients. We performed a literature search in MEDLINE (www.pubmed.org) with key words brain metastases, reirradiation, whole brain radiotherapy, stereotactic radiosurgery, interstial brachytherapy, and brain. The search was limited to the English literature and human subjects. |
doi_str_mv | 10.4103/0973-1482.57120 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_862874661</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A210079586</galeid><sourcerecordid>A210079586</sourcerecordid><originalsourceid>FETCH-LOGICAL-c469t-20278a1c1f0e786144cc81159fb070aac2cfbc4991b5bf3ebe556241d7812ec73</originalsourceid><addsrcrecordid>eNptkU1LAzEQhoMotlbP3qToebeZbHaTHEvxCwqC6Dlk00lJ6e7WZCv4701tUYSSQGDyvMkMDyHXQHMOtJhQJYoMuGR5KYDREzIEpWTGoZCnZPh7OyAXMa4oLQVj8pwMQEkOZVkNSf6KPgSz8Kb3XTt2XRhvQrcMGKP_xHEdjG_HDfYmpo3xkpw5s454dThH5P3h_m32lM1fHp9n03lmeaX6jFEmpAELjqKQFXBurQQolaupoMZYZl1tuVJQl7UrsMbUDOOwEBIYWlGMyO3-3dTMxxZjr1fdNrTpSy0rJgWvKkjQ3R5amjVq37quD8Y2Plo9ZUCpUKWsEpUdoZbYYjDrrkXnU_kfnx_h01pg4-3RwGQfsKGLMaDTm-AbE740UL2zpHce9M6D_rGUEjeH6bZ1g4s__qCl-AZ_hYla</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>862874661</pqid></control><display><type>article</type><title>Reirradiation for progressive brain metastases</title><source>MEDLINE</source><source>Medknow Open Access Journals</source><source>Bioline International</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Bahl, Amit ; Kumar, Milind ; Sharma, D N ; Jothy Basu, K S ; Jaura, M S ; Rath, G K ; Julka, P K</creator><creatorcontrib>Bahl, Amit ; Kumar, Milind ; Sharma, D N ; Jothy Basu, K S ; Jaura, M S ; Rath, G K ; Julka, P K</creatorcontrib><description>Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the primary modality for the treatment of multiple brain metastases, and improves both the quality of life and survival of patient. Unfortunately, more than half of these treated patients eventually progress leading to a therapeutic dilemma. Another course of radiotherapy is a viable but underutilized option. Reirradiation resolves distressing symptoms and has shown to improve survival with minimal late neurotoxicity. Reirradiation has conventionally been done with whole brain radiotherapy, but now studies with stereotactic radiosurgery have also shown promising results. In this review, we focus on reirradiation as a treatment modality in such patients. We performed a literature search in MEDLINE (www.pubmed.org) with key words brain metastases, reirradiation, whole brain radiotherapy, stereotactic radiosurgery, interstial brachytherapy, and brain. The search was limited to the English literature and human subjects.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/0973-1482.57120</identifier><identifier>PMID: 19841556</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Brachytherapy ; Brain cancer ; Brain Neoplasms - radiotherapy ; Brain Neoplasms - secondary ; Cancer ; Care and treatment ; Chemotherapy ; Cranial Irradiation - methods ; Development and progression ; Health aspects ; Humans ; Medical treatment ; Metastasis ; Quality of Life ; Radiation therapy ; Radiosurgery ; Radiotherapy ; Radiotherapy Dosage ; Radiotherapy, Adjuvant ; Retreatment ; Risk factors ; Survival Analysis ; Treatment Outcome</subject><ispartof>Journal of cancer research and therapeutics, 2009-07, Vol.5 (3), p.161</ispartof><rights>COPYRIGHT 2009 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt Ltd Jul 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c469t-20278a1c1f0e786144cc81159fb070aac2cfbc4991b5bf3ebe556241d7812ec73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19841556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bahl, Amit</creatorcontrib><creatorcontrib>Kumar, Milind</creatorcontrib><creatorcontrib>Sharma, D N</creatorcontrib><creatorcontrib>Jothy Basu, K S</creatorcontrib><creatorcontrib>Jaura, M S</creatorcontrib><creatorcontrib>Rath, G K</creatorcontrib><creatorcontrib>Julka, P K</creatorcontrib><title>Reirradiation for progressive brain metastases</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the primary modality for the treatment of multiple brain metastases, and improves both the quality of life and survival of patient. Unfortunately, more than half of these treated patients eventually progress leading to a therapeutic dilemma. Another course of radiotherapy is a viable but underutilized option. Reirradiation resolves distressing symptoms and has shown to improve survival with minimal late neurotoxicity. Reirradiation has conventionally been done with whole brain radiotherapy, but now studies with stereotactic radiosurgery have also shown promising results. In this review, we focus on reirradiation as a treatment modality in such patients. We performed a literature search in MEDLINE (www.pubmed.org) with key words brain metastases, reirradiation, whole brain radiotherapy, stereotactic radiosurgery, interstial brachytherapy, and brain. The search was limited to the English literature and human subjects.</description><subject>Brachytherapy</subject><subject>Brain cancer</subject><subject>Brain Neoplasms - radiotherapy</subject><subject>Brain Neoplasms - secondary</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Chemotherapy</subject><subject>Cranial Irradiation - methods</subject><subject>Development and progression</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Medical treatment</subject><subject>Metastasis</subject><subject>Quality of Life</subject><subject>Radiation therapy</subject><subject>Radiosurgery</subject><subject>Radiotherapy</subject><subject>Radiotherapy Dosage</subject><subject>Radiotherapy, Adjuvant</subject><subject>Retreatment</subject><subject>Risk factors</subject><subject>Survival Analysis</subject><subject>Treatment Outcome</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkU1LAzEQhoMotlbP3qToebeZbHaTHEvxCwqC6Dlk00lJ6e7WZCv4701tUYSSQGDyvMkMDyHXQHMOtJhQJYoMuGR5KYDREzIEpWTGoZCnZPh7OyAXMa4oLQVj8pwMQEkOZVkNSf6KPgSz8Kb3XTt2XRhvQrcMGKP_xHEdjG_HDfYmpo3xkpw5s454dThH5P3h_m32lM1fHp9n03lmeaX6jFEmpAELjqKQFXBurQQolaupoMZYZl1tuVJQl7UrsMbUDOOwEBIYWlGMyO3-3dTMxxZjr1fdNrTpSy0rJgWvKkjQ3R5amjVq37quD8Y2Plo9ZUCpUKWsEpUdoZbYYjDrrkXnU_kfnx_h01pg4-3RwGQfsKGLMaDTm-AbE740UL2zpHce9M6D_rGUEjeH6bZ1g4s__qCl-AZ_hYla</recordid><startdate>20090701</startdate><enddate>20090701</enddate><creator>Bahl, Amit</creator><creator>Kumar, Milind</creator><creator>Sharma, D N</creator><creator>Jothy Basu, K S</creator><creator>Jaura, M S</creator><creator>Rath, G K</creator><creator>Julka, P K</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20090701</creationdate><title>Reirradiation for progressive brain metastases</title><author>Bahl, Amit ; Kumar, Milind ; Sharma, D N ; Jothy Basu, K S ; Jaura, M S ; Rath, G K ; Julka, P K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c469t-20278a1c1f0e786144cc81159fb070aac2cfbc4991b5bf3ebe556241d7812ec73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Brachytherapy</topic><topic>Brain cancer</topic><topic>Brain Neoplasms - radiotherapy</topic><topic>Brain Neoplasms - secondary</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Chemotherapy</topic><topic>Cranial Irradiation - methods</topic><topic>Development and progression</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Medical treatment</topic><topic>Metastasis</topic><topic>Quality of Life</topic><topic>Radiation therapy</topic><topic>Radiosurgery</topic><topic>Radiotherapy</topic><topic>Radiotherapy Dosage</topic><topic>Radiotherapy, Adjuvant</topic><topic>Retreatment</topic><topic>Risk factors</topic><topic>Survival Analysis</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bahl, Amit</creatorcontrib><creatorcontrib>Kumar, Milind</creatorcontrib><creatorcontrib>Sharma, D N</creatorcontrib><creatorcontrib>Jothy Basu, K S</creatorcontrib><creatorcontrib>Jaura, M S</creatorcontrib><creatorcontrib>Rath, G K</creatorcontrib><creatorcontrib>Julka, P K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bahl, Amit</au><au>Kumar, Milind</au><au>Sharma, D N</au><au>Jothy Basu, K S</au><au>Jaura, M S</au><au>Rath, G K</au><au>Julka, P K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reirradiation for progressive brain metastases</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2009-07-01</date><risdate>2009</risdate><volume>5</volume><issue>3</issue><spage>161</spage><pages>161-</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>Brain metastases constitute one of the most common distant metastases of cancer and are increasingly being detected with better diagnostic tools. The standard of care for solitary brain metastases with the primary disease under control is surgery followed by radiotherapy. Radiotherapy is also the primary modality for the treatment of multiple brain metastases, and improves both the quality of life and survival of patient. Unfortunately, more than half of these treated patients eventually progress leading to a therapeutic dilemma. Another course of radiotherapy is a viable but underutilized option. Reirradiation resolves distressing symptoms and has shown to improve survival with minimal late neurotoxicity. Reirradiation has conventionally been done with whole brain radiotherapy, but now studies with stereotactic radiosurgery have also shown promising results. In this review, we focus on reirradiation as a treatment modality in such patients. We performed a literature search in MEDLINE (www.pubmed.org) with key words brain metastases, reirradiation, whole brain radiotherapy, stereotactic radiosurgery, interstial brachytherapy, and brain. The search was limited to the English literature and human subjects.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>19841556</pmid><doi>10.4103/0973-1482.57120</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0973-1482 |
ispartof | Journal of cancer research and therapeutics, 2009-07, Vol.5 (3), p.161 |
issn | 0973-1482 1998-4138 |
language | eng |
recordid | cdi_proquest_journals_862874661 |
source | MEDLINE; Medknow Open Access Journals; Bioline International; EZB-FREE-00999 freely available EZB journals |
subjects | Brachytherapy Brain cancer Brain Neoplasms - radiotherapy Brain Neoplasms - secondary Cancer Care and treatment Chemotherapy Cranial Irradiation - methods Development and progression Health aspects Humans Medical treatment Metastasis Quality of Life Radiation therapy Radiosurgery Radiotherapy Radiotherapy Dosage Radiotherapy, Adjuvant Retreatment Risk factors Survival Analysis Treatment Outcome |
title | Reirradiation for progressive brain metastases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A12%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reirradiation%20for%20progressive%20brain%20metastases&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Bahl,%20Amit&rft.date=2009-07-01&rft.volume=5&rft.issue=3&rft.spage=161&rft.pages=161-&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/0973-1482.57120&rft_dat=%3Cgale_proqu%3EA210079586%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=862874661&rft_id=info:pmid/19841556&rft_galeid=A210079586&rfr_iscdi=true |